Genetic Data Can Lead to Medical Discrimination: Cautionary tale of Opioid Use Disorder

Using genetics to predict the likelihood of future psychiatric disorders such as Opioid Use Disorder (OUD) poses scientific and ethical challenges. This report illustrates flaws in current machine learning (ML) approaches to such predictions using, as an example, a proposed genetic test for OUD derived from 16 candidate gene variants. In an independent sample of OUD cases and controls of European and African descent, results from five ML algorithms trained with purported "reward-system" candidate variants demonstrate that ML methods predict genomic ancestry rather than OUD. Further, sets of variants matched to the candidate SNPs by allele frequency produced similarly flawed predictions, questioning the plausibility of the selected candidate variants. We conclude that the genetic prediction of OUD (and by extension other highly polygenic psychiatric diseases) by ML has high potential to increase the likelihood of medical discrimination against population subgroups, with no benefit of accurate prediction for early intervention.

[1]  L. Farrer,et al.  Association of OPRM1 Functional Coding Variant With Opioid Use Disorder: A Genome-Wide Association Study. , 2020, JAMA psychiatry.

[2]  Ryan L. Collins,et al.  The mutational constraint spectrum quantified from variation in 141,456 humans , 2020, Nature.

[3]  Andrew B. Conley,et al.  Native American admixture recapitulates population-specific migration and settlement of the continental United States , 2019, PLoS genetics.

[4]  Patrick F Sullivan,et al.  No Support for Historical Candidate Gene or Candidate Gene-by-Interaction Hypotheses for Major Depression Across Multiple Large Samples. , 2019, The American journal of psychiatry.

[5]  Avi Ma'ayan,et al.  Predicting opioid dependence from electronic health records with machine learning , 2019, BioData Mining.

[6]  Matthew C. Keller,et al.  No Evidence That Schizophrenia Candidate Genes Are More Associated With Schizophrenia Than Noncandidate Genes , 2017, Biological Psychiatry.

[7]  L. Demers,et al.  Multi-variant Genetic Panel for Genetic Risk of Opioid Addiction. , 2017, Annals of Clinical and Laboratory Science.

[8]  B. Grant,et al.  Nonmedical Prescription Opioid Use and DSM-5 Nonmedical Prescription Opioid Use Disorder in the United States. , 2016, The Journal of clinical psychiatry.

[9]  Hongyu Zhao,et al.  Dissecting ancestry genomic background in substance dependence genome-wide association studies. , 2015, Pharmacogenomics.

[10]  田原 康玄,et al.  生活習慣病とgenome-wide association study , 2015 .

[11]  Jinbo Bi,et al.  Improved methods to identify stable, highly heritable subtypes of opioid use and related behaviors. , 2012, Addictive behaviors.

[12]  S. Meghani,et al.  Time to take stock: a meta-analysis and systematic review of analgesic treatment disparities for pain in the United States. , 2012, Pain medicine.

[13]  E. Mohammadi,et al.  Barriers and facilitators related to the implementation of a physiological track and trigger system: A systematic review of the qualitative evidence , 2017, International journal for quality in health care : journal of the International Society for Quality in Health Care.

[14]  Matthew C Keller,et al.  A critical review of the first 10 years of candidate gene-by-environment interaction research in psychiatry. , 2011, The American journal of psychiatry.

[15]  D. Hamer,et al.  Beware the chopsticks gene , 2000, Molecular Psychiatry.